Baalavatham (Paresis)- Siddha Thearapeutic management in Children

Preclinical and Clinical Assessment and Evaluavtion of Baalavatham (Paresis) with Siddha Thearapeutic management in Children - Baala Vaatham

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013296

Enrollment

Registered

2018-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Baalavaatham

Interventions

Intervention1: CHITRA MUTTI KUDINEER Baala vaatha thylam: Chitra mutti kudineer 5 to 15mltwice a day with palm jaggery for 45days Baalavaatha thylam external Control Intervention1: not applicable: no

Eligibility

Inclusion criteria

Inclusion criteria: Mono di tetra quadri paresis weakness of one or more limb loss of power and tone in muscles of the affected limb difficulty inability in using the affected limb against gravity and resistance difficulty in using the upper limb

Exclusion criteria

Exclusion criteria: epilepsy severe aggressiveness with ADHD autism cerebral palsy congenital heart disease any other serious illness

Design outcomes

Primary

Measure	Time frame
to reduce the muscle spastisity Timepoint: to reduce the muscle spasticity	—

Secondary

Measure	Time frame
spasticity assessment Range of motion assesment with goniometeryTimepoint: to reduce the muscle spasticity	—

Countries

India

Contacts

Public ContactG Ridhambara devi

National Institute of siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026